Ignite Creation Date:
2024-05-06 @ 1:20 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03995212
Status:
TERMINATED
Last Update Posted:
2023-07-03
First Post:
2019-06-19
Brief Title:
Study to Evaluate the Safety and Efficacy of Oral CR845 Difelikefalin in Patients With Primary Biliary Cholangitis PBC and Moderate-to-Severe Pruritus
Sponsor:
Cara Therapeutics Inc
Organization:
Cara Therapeutics Inc
Organization Data
Organization:
Cara Therapeutics Inc
Class:
INDUSTRY
Study ID:
CR845-210401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cara Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None